Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
多组学分析鉴定出一种高风险特征,可预测弥漫性大B细胞淋巴瘤(DLBCL)的早期临床失败。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01080-0
Wenzl, Kerstin; Stokes, Matthew E; Novak, Joseph P; Bock, Allison M; Khan, Sana; Hopper, Melissa A; Krull, Jordan E; Dropik, Abigail R; Walker, Janek S; Sarangi, Vivekananda; Mwangi, Raphael; Ortiz, Maria; Stong, Nicholas; Huang, C Chris; Maurer, Matthew J; Rimsza, Lisa; Link, Brian K; Slager, Susan L; Asmann, Yan; Mondello, Patrizia; Morin, Ryan; Ansell, Stephen M; Habermann, Thomas M; Witzig, Thomas E; Feldman, Andrew L; King, Rebecca L; Nowakowski, Grzegorz; Cerhan, James R; Gandhi, Anita K; Novak, Anne J